冠状动脉支架市场规模、份额和成长分析（按类型、输送方式、材料、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，冠状动脉支架市场规模将达到 4,484.7 亿美元，到 2025 年将达到 4,726.8 亿美元，到 2033 年将达到 7,199.4 亿美元，预测期（2026-2033 年）的复合年增长率为 5.4%。

由于心血管疾病发生率不断上升和人口老化，冠状动脉支架市场正经历强劲增长。生活方式的改变导致冠状动脉疾病等疾病的盛行率不断上升，进而推动了对冠状动脉支架的需求成长。微创手术的普及也进一步促进了支架的采用。支架技术的创新，特别是药物释放型和生物可吸收支架的出现，改善了患者的治疗效果，降低了血管再阻塞的风险，从而促进了支架从传统裸金属支架向更高级支架的转变。儘管存在这些积极趋势，但仍存在一些挑战，例如高昂的手术费用可能会限制低收入地区的患者获得治疗，以及严格的监管要求会使新产品的核准流程复杂化。此外，支架血栓症和血管再阻塞等併发症仍然是患者和医疗服务提供者关注的问题，影响整体市场趋势。

冠状动脉支架市场驱动因素

心血管疾病，尤其是冠状动脉疾病的日益流行，是全球冠状动脉支架市场的主要驱动力。生活方式的改变、不合理的饮食以及缺乏运动等因素加剧了这一日益严重的健康问题。随着越来越多的人受到这些生活方式相关问题的影响，对冠状动脉支架等有效医疗干预措施的需求也随之增长。因此，医疗服务提供者和製造商不得不满足这一迫切需求，从而进一步推动了市场成长。对改善心血管健康和控制相关风险的普遍关注，凸显了冠状动脉支架在现代医疗解决方案中的重要作用。

冠状动脉支架市场的限制因素

由于卫生监管机构严格的核准流程，冠状动脉支架市场面临许多挑战。这些严格的要求促使製造商进行全面的安全性和有效性评估，而这往往耗费大量时间和资源。由此产生的漫长而复杂的核准流程可能会延缓创新产品的上市。这项挑战限制了市场成长机会，并可能降低患者获得先进支架技术的机会，最终影响整个冠状动脉支架市场的发展。因此，克服这些监管障碍对于促进该领域的创新和改善患者照护至关重要。

冠状动脉支架市场趋势

冠状动脉支架市场正呈现向微创手术显着发展的趋势，这主要得益于经经皮冠状动脉介入治疗（PCI）的日益普及。这一转变反映了医疗保健领域整体以改善患者预后为导向的趋势，因为与传统开胸手术相比，微创手术能够缩短住院时间、加快康復速度并降低併发症风险。随着医疗机构将患者的舒适度和效率放在首位，对先进冠状动脉支架的需求预计将大幅增长，从而推动支架设计和输送系统的创新，以满足心血管护理领域不断变化的需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球冠状动脉支架市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 裸金属支架
• 药物释放型支架
• 生物可吸收支架

全球冠状动脉支架市场规模（按交付量和复合年增长率划分）（2026-2033 年）

• 球囊扩张型支架
• 自动扩张型支架

全球冠状动脉支架市场规模（按材料和复合年增长率划分）（2026-2033 年）

• 金属支架
• 钴铬
• 铂金铬
• 镍钛
• 不銹钢
• 其他支架

全球冠状动脉支架市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 心臟中心
• 门诊手术中心

全球冠状动脉支架市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Abbott Laboratories（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Biosensors International Group, Ltd.（Singapore）
• Biotronik SE & Co. KG（Germany）
• B. Braun Melsungen AG（Germany）
• Terumo Corporation（Japan）
• MicroPort Scientific Corporation（China）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Sahajanand Medical Technologies Pvt. Ltd.（India）
• Meril Life Sciences Pvt. Ltd.（India）
• Vascular Concepts（India）
• Translumina GmbH（Germany）
• Cordis Corporation（USA）
• Reva Medical, Inc.（USA）
• Elixir Medical Corporation（USA）
• Stentys SA（France）
• Alvimedica（Turkey）
• Balton Medical（Sweden）
• Cardionovum（USA）

结论与建议

Coronary Stent Market size was valued at USD 448.47 Billion in 2024 and is poised to grow from USD 472.68 Billion in 2025 to USD 719.94 Billion by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).

The coronary stent market is experiencing robust growth influenced by an increasing incidence of cardiovascular diseases and an aging population. As lifestyle changes contribute to higher rates of conditions like coronary artery disease, the demand for coronary stents is escalating. The shift towards minimally invasive procedures further drives adoption. Innovations in stent technology, particularly drug-eluting and bioresorbable designs, have enhanced patient outcomes and reduced restenosis risks, prompting a transition from traditional bare-metal options. Despite this positive trend, challenges persist, including high procedural costs that may restrict access in lower-income regions and stringent regulatory requirements that complicate approval processes for new products. Additionally, complications like stent thrombosis and restenosis remain concerns for patients and healthcare providers, impacting overall market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Coronary Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Coronary Stent Market Segments Analysis

Global Coronary Stent Market is segmented by type, delivery, material, end user and region. Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. Based on delivery, the market is segmented into balloon-expandable stents and self-expanding stents. Based on material, the market is segmented into metallic stents, cobalt chromium, platinum chromium, nickel titanium, stainless steel and other stents. Based on end user, the market is segmented into hospitals, cardiac centers and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Coronary Stent Market

The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, significantly propels the global coronary stent market. Factors such as shifts in lifestyle, poor dietary habits, and a lack of physical activity have all contributed to this escalating health concern. As more individuals face the consequences of these lifestyle-related issues, the demand for effective medical interventions, such as coronary stents, rises. Consequently, healthcare providers and manufacturers are compelled to respond to this urgent need, further driving market growth. The overall focus on improving cardiovascular health and managing associated risks emphasizes the crucial role of coronary stents in contemporary healthcare solutions.

Restraints in the Coronary Stent Market

The coronary stent market faces significant obstacles due to the rigorous regulatory approval processes enforced by health authorities. These stringent requirements necessitate that manufacturers undergo thorough safety and efficacy evaluations, which often consume considerable time and resources. As a result, the lengthy and complex approval procedures can hinder the timely introduction of innovative products into the market. This challenge can restrict growth opportunities and limit the availability of advanced stent technologies for patients, ultimately affecting the overall development of the coronary stent market. Addressing these regulatory hurdles is essential for fostering innovation and enhancing patient care in this field.

Market Trends of the Coronary Stent Market

The coronary stent market is witnessing a notable trend favoring minimally invasive procedures, primarily driven by the increasing adoption of percutaneous coronary intervention (PCI). This shift reflects a broader healthcare emphasis on enhancing patient outcomes, as minimally invasive approaches facilitate shorter hospital stays, quicker recovery times, and a decreased risk of complications when compared to traditional open-heart surgeries. As healthcare providers prioritize patient comfort and efficiency, the demand for advanced coronary stents is expected to surge, fostering innovations in stent design and delivery systems that align with these evolving preferences in cardiovascular care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Coronary Stent Market Size by Type & CAGR (2026-2033)

• Market Overview
• Bare-Metal Stents
• Drug-Eluting Stents
• Bioabsorbable Stents

Global Coronary Stent Market Size by Delivery & CAGR (2026-2033)

• Market Overview
• Balloon-Expandable Stents
• Self-Expanding Stents

Global Coronary Stent Market Size by Material & CAGR (2026-2033)

• Market Overview
• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Other Stents

Global Coronary Stent Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

Global Coronary Stent Market Size & CAGR (2026-2033)

• North America (Type, Delivery, Material, End User)
  • US
  • Canada
• Europe (Type, Delivery, Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Delivery, Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Delivery, Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Delivery, Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International Group, Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sahajanand Medical Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Concepts (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Translumina GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reva Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stentys SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvimedica (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balton Medical (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations